Activation of the b-receptor for platelet-derived growth factor (PDGF) by its ligand leads to autophosphorylation on a number of tyrosine residues. Here we show that Tyr763 in the kinase insert region is a novel autophosphorylation site, which after phosphorylation binds the protein tyrosine phosphatase SHP-2. SHP-2 has also previously been shown to bind to phosphorylated Tyr1009 in the PDGF b-receptor. Porcine aortic endothelial (PAE) cells transfected with a PDGF breceptor in which Tyr763 and Tyr1009 were mutated to phenylalanine residues failed to associate with SHP-2 after ligand stimulation. Morover, PDGF-BB-induced Ras GTP-loading and Erk2 activation were severely compromised in the receptor mutant. Whereas the mitogenic response to PDGF-BB remained at the same level as in cells expressing wild-type PDGF b-receptor, chemotaxis induced by PDGF-BB was signi®cantly decreased in the case of the Y763F/Y1009F mutant cells, suggesting an important role for SHP-2 in chemotactic signaling.
Introduction
Platelet-derived growth factor (PDGF) is a family of growth factors, consisting of homo-or heterodimers of disul®de-bonded A-and B-polypeptide chains. PDGF exerts its eect on target cells by binding to two structurally related tyrosine kinase receptors, the a and b receptors. Upon ligand-binding receptors dimerize, leading to activation of their intrinsic tyrosine kinase activities and autophosphorylation of speci®c tyrosine residues in the intracellular parts of the receptors (Heldin, 1995) . More than ten autophosphorylation sites have been identi®ed in the PDGF b-receptor, most of which constitute high anity binding sites for Src homology 2 (SH2) domain containing signaling molecules (reviewed in Claesson-Welsh, 1994) . One of the molecules binding to the activated PDGF breceptor is SHP-2. It is a ubiquitously expressed protein tyrosine phosphatase containing two SH2 domains that has been implicated in mitogenic signaling of a number of growth factor receptors, including the insulin receptor (Milarski and Saltiel, 1994) , the insulin-like growth factor-1 receptor and the epidermal growth factor (EGF) receptor (Xiao et al., 1994) . Overexpression of a catalytically compromised SHP-2 protein (Rivard et al., 1995) or microinjection of either a GST-fusion protein containing the SH2 domains of SHP-2 or neutralizing antibodies (Roche et al., 1996) inhibited PDGF-induced mitogenicity. It has previously been shown that Tyr1009 in the PDGF breceptor binds to SHP-2 (Kazlauskas et al., 1993) , and that the association between the SH2 domains of SHP-2 and its target proteins triggers activation of the phosphatase activity of SHP-2 Pluskey et al., 1995) . Simultaneous occupancy of both SH2 domains by phosphopeptides is required for full activation of the phosphatase activity of SHP-2 (Eck et al., 1996; Jackson et al., 1997; Ohnishi et al., 1996; Pluskey et al., 1995) . This suggests that additional autophosphorylation sites in the PDGF b-receptor might contribute to the activation of SHP-2.
In this report we present evidence that Tyr763 is an autophosphorylation site in the PDGF b-receptor and that it, together with Tyr1009, forms the binding site for SHP-2 in the PDGF b-receptor. The functional consequence of the binding and activation of SHP-2 was investigated using cells stably expressing a PDGF breceptor mutant with Tyr763 and Tyr1009 replaced with phenylalanine residues by site-directed mutagenesis.
Results

Identi®cation of Tyr763 as an autophosphorylation site in the PDGF b-receptor
In order to identify novel autophosphorylation sites in the PDGF b-receptor kinase insert, PAE cells expressing the wild-type PDGF b-receptor was labeled with 32 P-orthophosphate in vivo. After stimulation by PDGF-BB, the b-receptor was immunoprecipitated and and digested with trypsin. Since trypsin digestion of the PDGF b-receptor gives rise to a number of very large fragments containing several tyrosine residues each, they are dicult to analyse by two-dimensional phosphopeptide mapping. Therefore, the tryptic peptides were subjected to immunoprecipitation using a peptide antiserum, speci®cally recognizing a tryptic peptide comprising amino acid residues 763 ± 785 in the b-receptor (Kumjian et al., 1989) . The immunoprecipitated 32 P-labeled tryptic peptide was subjected to phosphoamino acid analysis and Edman degradation. The only phosphorylated amino acid present in the peptide was phosphotyrosine (data not shown), and upon Edman degradation a peak of radioactivity was released in cycle 1 (corresponding to Tyr763) ( Figure  1a ), in cycle 9 (corresponding to Tyr771), as well as minor amounts in later cycles. To verify that Tyr763 is an autophosphorylation site, a similar experiment was performed on PAE cells expressing a b-receptor with Tyr763 replaced with a phenylalanine residue. In this case, no peak of radioactivity was seen in cycle 1 (Figure 1b) , verifying that Tyr763 is a novel autophosphorylation site.
Identi®cation of the protein associating with phosphorylated Tyr763 in the PDGF b-receptor as SHP-2
In order to identify protein(s) that bind to phosphorylated Tyr763 in the b-receptor, a synthetic peptide was made, corresponding to the amino acid sequence surrounding Tyr763, either phosphorylated or non-phosphorylated, and coupled covalently to Agel 10. When a lysate of metabolically labeled PAE cells was applied to the beads, a protein of approximately 65 kDa was found to bind to the phosphorylated Tyr763 peptide, but not to the nonphosphorylated peptide. Furthermore, the binding of the 65 kDa component to the immobilized, phosphorylated Tyr763 peptide could be competed with soluble phosphorylated Tyr763 peptide, but not with the non-phosphorylated Tyr763 peptide. Very weak binding of other proteins were seen to the phosphorylated Tyr763 peptide column, and this binding was not dependent on the phosphorylation state of Tyr763.
Using phosphorylated Tyr763 peptide coupled to Agel 10 as an anity matrix, the 65 kDa component was puri®ed from a lysate of 10 10 HeLa cells. The puri®ed protein was separated by SDS-gel electrophoresis ( Figure 2a ) and subjected to in-gel digestion with endoproteinase Lys-C. The resulting proteolytic digest was separated by HPLC. Two peptides, denoted 1 and 2, were sequenced, both yielding complete identity with sequences of the protein tyrosine phosphatase SHP-2 (Figure 2b ). Figure 2 Anity puri®cation of components binding to phosphorylated Tyr763. By use of an immobilized synthetic phosphopeptide corresponding to the sequence surrounding Tyr763 in the PDGF b-receptor, interacting protein(s) in a lysate of HeLa cells were enriched. After separation by SDS-gel electrophoresis and staining with Coomassie, one major band was seen (a). The protein was digested in situ with endoproteinase Lys-C. The resulting proteolytic peptides were separated by reversed phase chromatography (b). Two peptides, denoted 1 and 2, were sequenced, revealing a complete identity with SHP-2 Tyr763, as well as Tyr1009, constitute in vivo binding sites for SHP-2 in the PDGF b-receptor
In order to study the function of Tyr763 phosphorylation in vivo, we mutated Tyr763 to a phenylalanine residue, either singly or together with Tyr1009, a previously identi®ed site for binding of SHP-2 in the PDGF b-receptor (Kazlauskas et al., 1993) , and expressed the mutant receptors in PAE cells. Stimulation of cells with PDGF-BB followed by immunoprecipitation with an antiserum against SHP-2 showed coimmunoprecipitation of the PDGF b-receptor in cells expressing the wild-type receptor, while in cells expressing either Y763F or Y1009F mutant receptor, association was dramatically reduced (Figure 3 ). The loss of association was greater in the Y1009F than in the Y763F mutant, suggesting that Tyr1009 is the major site of association of SHP-2. In cells expressing the Y763F/Y1009F double mutant, no association was seen. Thus both phosphorylation sites are important for a high anity interaction between SHP-2 and the PDGF b-receptor.
SHP-2 binding to the PDGF b-receptor is important for mediation of Erk2 activation and Ras GTP-loading Zhao et al. (1995) demonstrated that overexpression of SHP-2 in 293 cells led to increased EGF-induced MAP kinase activation, whereas overexpression of the corresponding catalytically inactive mutant of SHP-2 led to a decrease in MAP kinase activation. Similarly, Yamauchi et al. (1995) found that a dominant negative form of SHP-2 blocked insulin stimulation of Erk1 and Erk2 activation, suggesting an involvement of SHP-2 in stimulation of the MAP kinase cascade.
When assaying cells expressing either wild-type receptor, or Y763F, Y1009F or Y763F/Y1009F receptor mutants for Erk2 activation, it was seen that both single mutants had a marked decrease in PDGF-BB-induced Erk2 activation, while the duration of response was unchanged (Figure 4) . Cells expressing the Y763F/Y1009F receptor mutant showed an even lower Erk2 activation. One mechanism of activation of the MAP kinase cascade is via activation of Ras, which then physically interacts with and activates Raf-1, the ®rst kinase in the cascade. Notably, PDGF-BB-induced Ras GTP-loading was signi®cantly lowered and transient in cells expressing the Y763F/Y1009F receptor mutant, while the response was strong and remained longer in the wild-type receptor expressing cells ( Figure 5 ).
PDGF-BB induces a mitogenic response in Y763F/Y1009F mutant PDGF receptor-expressing cells
The Ras/MAP kinase pathway has been shown to be crucial for mitogenic signaling of a number of growth factors (Cai et al., 1990; Mulcahy et al., 1985) . Thus, we tested whether the Y763F/Y1009F mutation aected mitogenic signaling. Surprisingly, the mitogenic response elicited by the Y763F/Y1009F mutant PDGF b-receptor was as strong as that of the wildtype receptor (Figure 6 ).
Decreased chemotaxis in response to PDGF-BB in cells expressing the Y763F/Y1009F mutant receptor Overexpression of either constitutively active or a dominant negative form of Ras in NIH3T3 cells has been reported to inhibit chemotaxis, suggesting an involvement of Ras in the chemotactic response in these cells (Kundra et al., 1995) . This ®nding prompted us to investigate whether the Y763F/Y1009F mutation aected chemotaxis, since it had a profound eect on PDGF-induced Ras GTP-loading. Using a Boyden chamber assay, we found that the Y763F and Y1009F mutants exerted a lower chemotactic response than the wild-type receptor, and that the Y763F/Y1009F mutant exerted even lower chemotactic response, both at lower and higher doses of PDGF-BB (Figure 7 ).
Discussion
We show in this report that a PDGF b-receptor mutant unable to bind SHP-2 is defective in its ability to activate important signaling pathways, such as the Ras/MAP kinase pathway. Whereas the receptor mutant induced a mitogenic response after PDGF-BB-stimulation, its capability to induce a chemotactic response was strongly diminished.
SHP-2, which has two SH2 domains in its aminoterminal part, has previously been shown to bind with high anity to Tyr1009 in the PDGF b-receptor (Kazlauskas et al., 1993; Lechleider et al., 1993) . Using a peptide library approach, Songyang et al. (1993) de®ned Y-I/V-X-V/I/L/P as an optimal sequence for binding to the N-terminal SH2 domain of SHP-2; the identi®ed motif is similar to the sequence surrounding Tyr1009, but not to the sequence surrounding Tyr763. One possible explanation is that the two SH2 domains of SHP-2 have dierent binding speci®city. When comparing the sequences surrounding naturally occuring association sites for SHP-2, Tyr763 is quite similar to the association sites found in a number of other molecules (Table 1) (Case et al., 1994; Fujioka et al., 1996; Jackson et al., 1997; Ohnishi et al., 1996; Ottinger et al., 1998; Sugimoto et al., 1994) . Many of these molecules have an alanine residue in position +1, an acidic residue in position +2, followed by either leucine or isoleucine in position +3. It should be noted that we were unable to identify any other proteins binding to Tyr763 in a phosphorylation dependent manner.
It has been shown that SHP-2 can dephosphorylate the autophosphorylated PDGF b-receptor, and possibly also its substrates, and thereby act in a negative manner in signaling (Klinghoer and Kazlauskas, 1995) . Saxton et al. (1997) found that murine ®broblasts carrying a mutated version of SHP-2, lacking the aminoterminal SH2 domain and with a non-functional carboxyterminal SH2 domain, responded to PDGF-BB with increased MAP kinase activation compared to wild-type cells, consistent with a negative control function of SHP-2 in PDGFmediated activation of MAP kinase. However, these data dier from ®ndings by Lu et al. (1998) , who showed a decreased PDGF-induced MAP kinase activity in SV40 large T immortalized ®broblasts, expressing an identically mutated SHP-2; however, the interpretation is complicated by the fact that the immortalized ®broblasts carrying the SHP-2 mutation express dramatically lower levels of PDGF b-receptor than wild-type cells . The data presented in the present work show that a PDGF b- Tyr763  Tyr1009  Tyr1172  Tyr1222  Tyr954  Tyr425  Tyr663  Tyr686  Tyr436  Tyr460  Tyr477  Tyr501   DVKYADIESS  SVLYTAVQPN  SLNYIDLDLV  LSTYASINFQ  PQRYLVIQGD  SFEYTILDPS  DVQYTEVQVS  ETVYSEVRKA  DITYADLNLL  HTEYASIETG  TLTYADLDMV  FSEYASVQVQ The consensus sequence obtained from peptide library binding to the N-terminal SH2 domain of SHP-2 was determined to Y I/V X V/I/L/ P (Songyang et al., 1993) PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis L Ro Ènnstrand et al receptor Y763F/Y1009F mutant, unable to bind SHP-2, mediates MAP kinase activation less eciently than wild-type receptors. A possible explanation for the discrepancy in results could be that in cells with the PDGF b-receptor mutant, SHP-2 may interact also with components other than the PDGF b-receptor that might be important for regulation of MAP kinase signaling. In addition to the potential negative function of SHP-2 in PDGF receptor signaling, there are several examples suggesting that SHP-2 is also involved in positive signaling. Although originally suggested to provide a link between SHP-2 and Grb-2/SOS (Bennett et al., 1994; Li et al., 1994) , it has been shown in several systems that the phosphorylation of SHP-2 on tyrosine residues is of minor importance for activation of the Ras/MAP kinase pathway (Bennett et al., 1996; Tang et al., 1995) . Although SHP-2 may contribute to PDGF-induced mitogenesis through its ability to act as an adaptor which binds to Grb2, studies in which activation of SHP-2 were blocked by overexpression of a catalytically compromised SHP-2 suggests that also the phosphatase activity of SHP-2 is important for growth factor induced mitogenesis (Rivard et al., 1995; Roche et al., 1996; Xiao et al., 1994) . Furthermore, Bennett et al. (1996) found that either catalytically compromised SHP-2 or a version of SHP-2 lacking the Grb2 binding site failed to inhibit Elk-1 induction in response to PDGF, suggesting that both Grb2 association and the phosphatase activity of SHP-2 are important for signaling.
As has previously been pointed out, the Ras/MAP kinase pathway is in many cell systems essential for mediation of a mitogenic response to growth factors. In the case of PAE cells, however, there seems to be a redundancy in pathways leading to mitogenicity; no eect on the mitogenic response to PDGF-BB was observed when cells expressing a PDGF b-receptor mutated at Tyr763 and Tyr1009 were analysed. It should also be noted that activation of the Ras/MAP kinase pathway does not always correlate with mitogenicity; in some cell systems activation of the Ras/MAP kinase pathway leads to growth inhibition and dierentiation (Pang et al., 1995; Pumiglia and Decker, 1997; Ravi et al., 1998) .
In contrast to the lack of eect on mitogenicity, there was a marked eect on the chemotactic response elicited by PDGF-BB in PAE cells expressing the Y763F/Y1009F mutant receptor. It has previously been shown that overexpression of either constitutively active or a dominant negative form of Ras in NIH3T3 cells leads to an abrogation of the chemotactic response (Kundra et al., 1995) . One downstream target for Ras is the small G-protein Rac1 Ridley et al., 1992) . Rac1 is also activated by PI3'-kinase (Hawkins et al., 1995) , which has been demonstrated to be important for PDGF breceptor mediated chemotaxis (WennstroÈ m et al., 1994) . Interestingly, Anand-Apte et al. (1997) showed that PDGF-BB-induced migration of Rat1 ®broblasts was inhibited by a dominant negative form of Rac1, whereas it was not inhibited by either a dominant negative form of MEK1 or by a MEK-speci®c inhibitor. The notion that Rac1 is important for PDGF-induced chemotaxis is also supported by studies using transfected PAE cells (Hooshmand-Rad et al., 1997). It is thus possible that both PI3'-kinase and Ras are needed for optimal Rac1 activation and an ecient chemotactic response by PDGF-BB.
Consistent with the notion that SHP-2 is of importance for cell motility, murine ®broblasts carrying an inactivating mutation of SHP-2 showed impaired spreading and migration on ®bronectin, compared to wild-type cells (Yu et al., 1998) . SHP-2 mutant cells contained an increased number of focal adhesions and showed a reduced FAK dephosphorylation, suggesting a role for SHP-2 in the dynamic interaction with the substratum, which is important for cell motility. Altered FAK activation has also been observed in PAE cells carrying a Y1009F mutant PDGF b-receptor (L Claeson-Welsh, personal communication).
Our data show that SHP-2 is an important mediator of PDGF-BB-induced activation of the Ras/MAP kinase pathway in PAE cells. The activation of the Ras/MAP kinase pathway that remains in the Y763F/ Y1009F mutant cells is sucient for mitogenesis, whereas PDGF-BB induced chemotaxis seems to be more dependent on an intact Ras activation.
Materials and methods
Antisera
Antibodies against SHP-2 was from Santa Cruz (sc-280) and antiphosphotyrosine antibodies PY20 from Transduction Laboratories. An antiserum recognizing Erk2 was prepared by immunizing rabbits with a peptide from the carboxyterminus of Erk2 (Leevers and Marshall, 1992) . Hybridoma producing antibody Y13-259 against Ras was purchased from ATCC. An antiserum recognizing amino acids 739 ± 757 of the murine PDGF b-receptor, cross-reacting with the human PDGF b-receptor, was a kind gift of Dr Thomas O Daniel (Kumjian et al., 1989) .
Mutagenesis and transfection
Site-directed mutagenesis was performed on a cDNA encoding the full-length PDGF b-receptor (Claesson-Welsh et al., 1988) using the Altered Sites in vitro Mutagenesis System (Promega). The mutations were con®rmed by DNA sequencing. The mutated cDNA was subcloned into the eukaryotic expression vector pcDNA3 (InVitrogen) and subsequently transfected into PAE cells by electroporation. Clones were selected for G418 resistance as previously described (Claesson-Welsh et al., 1988) .
Immunoprecipitation and Western blotting
Subcon¯uent PAE cells expressing either wild-type PDGF breceptor, or Y763F, Y1009F, or Y763F/Y1009F receptor mutants, were starved in Ham's F-12 containing 0.3% fetal calf serum (FCS) overnight. After incubation with 50 mM Na 3 VO 4 for 30 min at 378C, the¯asks were transferred to ice, and stimulated or not with 100 ng/ml PDGF-BB, for 1 h on ice. Cells were washed twice with ice-cold PBS, lysed and processed for either immunoprecipitation with a-SHP-2 antibodies (Santa Cruz) or incubation with wheat germ agglutinin-Sepharose, as described (Eriksson et al., 1995) . After boiling in reducing Laemmli buer, samples were separated by SDS-gel electrophoresis on a 7% gel, electrotransferred to an Immobilon P membrane, blocked with bovine serum albumin (BSA) in PBS overnight, and probed with PY20 antiphosphotyrosine antibodies, essentially as described by Blume-Jensen et al. (1993) .
In vivo 32 P-orthophosphate labeling of cells Labeling of cells with 32 P-orthophosphate, stimulation with PDGF-BB, lysis and immunoprecipitation was performed essentially as described by Hansen et al. (1996) , using PY20 anti-phosphotyrosine antibodies to immunoprecipitate the PDGF b-receptor.
Immunoprecipitation of peptides and automated Edman degradation
After separation of immunoprecipitated protein on SDS-gel electrophoresis, the proteins were electrotransferred to Hybond C-Extra ®lters and processed for trypsin digestion and immunoprecipitation as described (Hansen et al., 1996) with the exception that an antiserum against amino acid residues 771 ± 789 in the human PDGF b-receptor was used. Immunoprecipitated peptides were eluted, coupled to Sequelon AA membranes and subjected to automated Edman degradation (Blume-Jensen et al., 1995) .
Phosphopeptide anity chromatography
A peptide corresponding to the sequence surrounding Tyr763 in the PDGF b-receptor plus three additional lysine residues (GDVKYADIESSNKKK) was synthesized using Fmoc chemistry and the tyrosine residue phosphorylated according to Andrews et al. (1991) , as described (Mori et al., 1993) . The peptide was coupled to Agel 10 and used as an anity matrix. Puri®cation of interacting proteins from a lysate of 10 10 HeLa cells was performed as described (Hansen et al., 1996) . Bound proteins were eluted with reducing Laemmli buer, and separated on a 7% SDSpolyacrylamide gel. After Coomassie staining a major 65 kDa band was cut out, and subjected to in gel Lys-C protease digestion, followed by separation of peptides by narrow bore reversed phase liquid chromatography on a mRPC C2/C18 SC 2.1/10 column, operated in SMART System (Pharmacia Biotech, Uppsala, Sweden), as described . Peptides were sequenced on an Applied Biosystems Model 470A following the manufacturer's instructions.
MAP kinase assay
Subcon¯uent cells were starved overnight in 0.3% FCS in Ham's F-12 and stimulated with 100 ng/ml PDGF-BB at 378C for the indicated time. Cells lysates were prepared, and immunoprecipitation performed using an antiserum against Erk2 (Leevers and Marshall, 1992) . Erk2 kinase was assayed essentially according to Reuter et al. (1995) , using myelin basic protein as a substrate. The amount of radioactivity incorporated into MBP was quantitated using a Fuji BAS2000 Bioimager.
Ras GTP-loading
Subcon¯uent cell cultures were starved in 0.3% FCS in Ham's F-12 overnight. Measurement of Ras GTP-loading following PDGF-BB stimulation was done on 32 P-orthophosphate labeled cells, essentially as described by Burgering et al. (1991) . The amount of GTP and GDP that was bound to Ras, was quanti®ed using a Fuji BAS2000 Bioimager.
Mitogenicity assay
The [ 3 H]thymidine incorporation assay was performed as described (Mori et al., 1991) , except that cells were starved in 0.3% FCS in Ham's F-12 before stimulation with PDGF-BB.
Chemotaxis assay
Chemotaxis was measured using a Boyden chamber using Costar nucleopore ®lters coated with type I collagen, essentially as described by Kanda et al. (1996) . The assays were performed in Ham's F-12 containing 0.25% BSA.
